Ying-Lun Ou
Papers
1
Total Citations
2
H-Index
1
About
Dr. Ying-Lun Ou is a urological researcher whose work centers on improving prostate cancer risk stratification, particularly in obese patients. His key contributions address the limitations of standard prostate-specific antigen (PSA) testing, which can be confounded by body mass. In his highly cited 2024 study, Dr. Ou introduced body mass-weighted PSA levels as novel biomarkers to more accurately predict locally advanced prostate cancer following prostatectomy. This work directly tackles a critical gap in clinical practice, where obesity can mask true disease severity. By demonstrating that adjusting PSA for body mass improves prognostic accuracy, his research offers a practical, low-cost tool to refine surgical decision-making and postoperative management. Though early in its citation impact, the study’s immediate relevance to the obesity epidemic and precision oncology signals its growing influence. Dr. Ou’s work exemplifies how integrating patient-specific physiological factors can enhance the utility of established cancer markers, potentially reducing both overtreatment and underdetection in vulnerable populations.
Research Focus
Key Achievements
Top Papers
- 1